David Penn, MD
Vascular & Interventional Radiology · Stockbridge, GANPI 1760644355
Payments from drug & device makers
What this record shows
The money is spread across several categories — other (41.3%), food and beverage and education — rather than concentrated in one kind of arrangement. Angiodynamics, Inc. accounts for 62.9% of it on its own, with 32 other manufacturers making up the rest.
Across 211 payments — averaging $73.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$10K
- Bard Peripheral Vascular, Inc.$700
- Johnson & Johnson$654
- W. L. Gore & Associates, Inc.$520
- Medtronic$488
- Endologix LLC$415
- plus $3K from 27 others
What the payments were for
- Food & beverage$5,89938%
- Education$3,21021%
- Other$6,40041%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 13 | $9,752 |
| Bard Peripheral Vascular, Inc. | 25 | $700 |
| Johnson & Johnson | 39 | $654 |
| W. L. Gore & Associates, Inc. | 14 | $520 |
| Medtronic(2 entities) | 22 | $488 |
| Endologix LLC | 5 | $415 |
| Inari Medical, Inc. | 9 | $406 |
| Pfizer | 15 | $367 |
| Boston Scientific | 10 | $312 |
| Argon Medical Devices, Inc. | 4 | $304 |
| Penumbra, Inc. | 5 | $302 |
| Cardiovascular Systems Inc. | 10 | $264 |
| Philips North America LLC | 8 | $248 |
| Shockwave Medical, Inc | 1 | $164 |
| Cook Medical LLC | 6 | $102 |
| Stryker | 1 | $72 |
| Tactile Systems Technology Inc | 4 | $65 |
| E.r. Squibb & Sons, L.L.C. | 3 | $55 |
| Abbott | 2 | $46 |
| Imperative Care, Inc | 2 | $42 |
| Veryan Medical Incorporated | 1 | $31 |
| Baxter Healthcare | 1 | $27 |
| Neuros Medical, Inc. | 1 | $22 |
| Portola Pharmaceuticals, LLC | 1 | $21 |
| Hydrofera LLC | 1 | $20 |
| Integra Lifesciences Corporation | 1 | $18 |
| Cordis US CORP. | 1 | $16 |
| Cashflow Solutions, LLC | 1 | $15 |
| Aroa Biosurgery Incorporated | 1 | $15 |
| Nevro Corp. | 1 | $14 |
| EKOS Corporation | 1 | $14 |
| Medline Industries LP | 1 | $11 |
| Reprise Biomedical, Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VenaCure 1470 Pro$8,000
- EVLT$1,610
- Alto Abdominal Stent Graft System$259
- Indigo System$253
- Clot Management$229
- Chameleon$203
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$164
- COVERA$148
- GENERAL ATHERECTOMY$145
- FlowTriever$134
- ClotTriever$134
- VIABAHN Endoprosthesis with Heparin Bioactive Surface$129
- AFX$128
- VIABAHN VBX Balloon Expandable Endoprosthesis$127
How this compares
$15,509 in reported general payments places this provider in the 80th percentile of 120 vascular & interventional radiology providers in Georgia.
See all vascular & interventional radiology providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 116 | $124,195 |
| XareltoRivaroxaban | 26 | $26,013 |
| Tobramycin Sulfate | 14 | $25,791 |
| Varenicline Tartrate | 19 | $5,076 |
| Cilostazol | 260 | $4,723 |
| Pentoxifylline | 126 | $3,436 |
| ClopidogrelClopidogrel Bisulfate | 172 | $1,872 |
| Gabapentin | 117 | $1,075 |
| Pantoprazole Sodium | 82 | $624 |
| Esomeprazole Magnesium | 11 | $536 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 11 | $186 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 17 | $163 |
| Famotidine | 20 | $123 |
| Doxycycline Monohydrate | 13 | $119 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $108 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $367 | $124,195116 claims |
| Johnson & JohnsonXarelto | $654 | $26,01326 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 120 vascular & interventional radiology providers in Georgia.
Other vascular & interventional radiology in Stockbridge
- Sachin ShethStockbridge$46K
- David AllisonStockbridge$19K
- Charles GillilandStockbridge$15K
- Ayman AbunimerStockbridge$4K
- Nima KokabiAtlanta$1M
- Jason LevyAtlanta$822K
- Aravind ArepallyAtlanta$249K
- Kei YamadaAtlanta$154K
- Charles TeeslinkAugusta$135K
- Kirema Garcia-ReyesAtlanta$115K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.